ZYMEWORKS INC. Basic Shares Outstanding (Weighted Average)
ZYMEWORKS INC. (ZYME) reported Basic Shares Outstanding (Weighted Average) of 72.99 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 72.99M shares, a 3.11% decline year-over-year.
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 74.67M shares, a 0.67% decline year-over-year.
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 75.34M shares, a 0.92% increase year-over-year.
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 75.77M shares, a 0.47% decline year-over-year.
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 75.40M shares, a 0.58% decline from fiscal 2024.
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 75.85M shares, a 10.14% increase from fiscal 2023.
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 68.86M shares, a 5.63% increase from fiscal 2022.
- ZYMEWORKS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 65.19M shares, a 26.46% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 72.99M shares 10-Q · filed 2026-08-06 | 73.83M shares 10-Q · filed 2026-08-06 | 74.33M shares derived: average of 3 quarters · filed 2026-08-06 | 74.69M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 74.67M shares 10-Q · filed 2026-05-07 | 75.00M shares derived: average of 2 quarters · filed 2026-05-07 | 75.26M shares derived: average of 3 quarters · filed 2026-05-07 | 75.28M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 75.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 75.55M shares derived: average of 2 quarters · filed 2026-03-02 | 75.48M shares derived: average of 3 quarters · filed 2026-08-06 | 75.40M shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 75.77M shares 10-Q · filed 2025-11-06 | 75.55M shares derived: average of 2 quarters · filed 2026-08-06 | 75.43M shares 10-Q · filed 2025-11-06 | 75.23M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 75.34M shares 10-Q · filed 2026-08-06 | 75.25M shares 10-Q · filed 2026-08-06 | 75.05M shares derived: average of 3 quarters · filed 2026-08-06 | 75.32M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 75.17M shares 10-Q · filed 2026-05-07 | 74.91M shares derived: average of 2 quarters · filed 2026-05-07 | 75.32M shares derived: average of 3 quarters · filed 2026-05-07 | 75.59M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 74.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 75.39M shares derived: average of 2 quarters · filed 2026-03-02 | 75.72M shares derived: average of 3 quarters · filed 2026-03-02 | 75.85M shares 10-K · filed 2026-03-02 |
| 2024-09-30 | 76.13M shares 10-Q · filed 2025-11-06 | 76.26M shares derived: average of 2 quarters · filed 2025-11-06 | 76.24M shares 10-Q · filed 2025-11-06 | 74.89M shares derived: average of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | 76.39M shares 10-Q · filed 2025-08-07 | 76.30M shares 10-Q · filed 2025-08-07 | 74.47M shares derived: average of 3 quarters · filed 2026-03-02 | 73.50M shares derived: average of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | 76.21M shares 10-Q · filed 2025-05-08 | 73.51M shares derived: average of 2 quarters · filed 2026-03-02 | 72.53M shares derived: average of 3 quarters · filed 2026-03-02 | 71.22M shares derived: average of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | 70.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 70.69M shares derived: average of 2 quarters · filed 2026-03-02 | 69.56M shares derived: average of 3 quarters · filed 2026-03-02 | 68.86M shares 10-K · filed 2026-03-02 |
| 2023-09-30 | 70.58M shares 10-Q · filed 2024-10-31 | 68.93M shares derived: average of 2 quarters · filed 2024-10-31 | 68.21M shares 10-Q · filed 2024-10-31 | 67.78M shares derived: average of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | 67.28M shares 10-Q · filed 2024-08-01 | 67.01M shares 10-Q · filed 2024-08-01 | 66.85M shares derived: average of 3 quarters · filed 2025-03-05 | 66.76M shares derived: average of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | 66.74M shares 10-Q · filed 2024-05-02 | 66.63M shares derived: average of 2 quarters · filed 2025-03-05 | 66.58M shares derived: average of 3 quarters · filed 2025-03-05 | 66.52M shares derived: average of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | 66.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | 66.50M shares derived: average of 2 quarters · filed 2025-03-05 | 66.45M shares derived: average of 3 quarters · filed 2025-03-05 | 65.19M shares 10-K · filed 2025-03-05 |
| 2022-09-30 | 66.48M shares 10-Q · filed 2023-11-07 | 66.42M shares derived: average of 2 quarters · filed 2023-11-07 | 64.75M shares 10-Q · filed 2023-11-07 | 61.49M shares derived: average of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | 66.35M shares 10-Q · filed 2023-08-10 | 63.87M shares 10-Q · filed 2023-08-10 | 59.83M shares derived: average of 3 quarters · filed 2024-03-06 | 57.79M shares derived: average of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | 61.37M shares 10-Q · filed 2023-05-08 | 56.57M shares derived: average of 2 quarters · filed 2024-03-06 | 54.93M shares derived: average of 3 quarters · filed 2024-03-06 | |
| 2021-12-31 | 51.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | 51.71M shares derived: average of 2 quarters · filed 2024-03-06 | 51.55M shares 10-K · filed 2024-03-06 | |
| 2021-09-30 | 51.66M shares 10-Q · filed 2022-11-08 | 51.48M shares 10-Q · filed 2022-11-08 | ||
| 2020-12-31 | 50.38M shares 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |